Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD Source: Eur Respir J 2001; 18: 122S-126S Year: 2001
The perpetrator potential of sitaxentan based on its ability to inhibit human cytochrome P450 (CYP) enzymes Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008
Absence of inhibitory effect of levocetirizine on the metabolism of human cytochrome P450 model substrates Source: Eur Respir J 2005; 26: Suppl. 49, 136s Year: 2005
Lipid mediators in severe asthma Source: Eur Respir Mon 2011; 51: 218-235 Year: 2011
Genetic polymorphisms in the cytochromes P450, microsomal epoxide hydrolase and glutathione S-transferase M1, T1 and P1 genes and their relationship to relapsing bronchitis and pneumonia in case of children Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005
Effects of aryl hydrocarbon receptor and cytochrome P450 1A1 polymorphisms on childhood lung function and asthma Source: Eur Respir J 2007; 30: Suppl. 51, 296s Year: 2007
Effects of zileuton on leukotriene formation in human blood cells and expression of enzymes in the biosynthetic pathway Source: Eur Respir J 2006; 28: Suppl. 50, 316s Year: 2006
Cytosolic phospholipase A2 type IVβ induces interleukin – 8 and cyclooxygenase -2 gene expression but does not influence IL-16 and heme oxygenase-1 transcription in human lung cells Source: Annual Congress 2004 - Inflammation and remodelling in human lungs Year: 2004
Association analysis between polymorphisms in the cytochrome P450 2J2, 2S1 and UDP-glucuronosyltransferase 2B7 genes with occupational chronic bronchitis Source: Annual Congress 2010 - Genetics of obstruction Year: 2010
Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD Source: Eur Respir J 2008; 32: 931-937 Year: 2008
The victim potential of sitaxentan: metabolism by human CYP450 enzymes Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008
PGD2 biosynthesis in several human mast cell models is catalyzed by cycloxygenase-1 Source: Annual Congress 2011 - Mechanisms of allergic inflammation of the airways Year: 2011
IL-8 and COX-2 expression is regulated through cPLA2-derived arachidonate metabolites in human lung cells Source: Annual Congress 2003 - Intracellular signalling and regulation of cytokine production Year: 2003
COX-1 driven biosynthesis of PGD2 during activation of human mast cells prevents formation of other prostanoids Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes Year: 2020
Interactions between roflumilast and cytochrome P450 inducers and inhibitors: Overview of existing studies Source: Annual Congress 2010 - Management of airway disease Year: 2010
IL-13 enhances GSNO reductase activity and decreases intracellular S-nitrosothiols in lung epithelial cells Source: Eur Respir J 2006; 28: Suppl. 50, 103s Year: 2006
Dexamethasone accelerates catabolism of leukotriene C4 in bronchial epithelial cells Source: Eur Respir J 2003; 22: 35-42 Year: 2003
Xanthine oxidase inhibitors reduce rhinovirus induced IL-8 and GRO-α production in bronchial epithelial cells Source: Eur Respir J 2007; 30: Suppl. 51, 721s Year: 2007
Polymorphisms for epoxide hydrolase, glutathione transferase and genetic susceptibility to COPD Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020